Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-14-072144)

Filing Details

Accession Number:: 0001144204-14-072144
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-12-03 16:54:08
Reporting Period:: 2014-11-26

Filing Date:: 2014-12-03
Accepted Time:: 2014-12-03 16:54:08
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1208261	Immune Pharmaceuticals Inc	IMNP	Pharmaceutical Preparations (2834)	521841431

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1277161	David Sidransky	Cambridge Innovation Center One Broadway, 14Th Floor Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-11-26	10,400	$2.50	18,290	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2014-11-26	2,600	$0.00	2,600	$3.75

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2,600	2014-11-26	2017-11-26	No	4	P	Direct

Footnotes

The securities were purchased by the Reporting Person in connection with the underwriter's partial exercise of its over-allotment option to purchase additional units in the Issuer's underwritten public offering that closed on November 25, 2014.